Fidelity Disruptive Medicine ETF

23.63

+0.0000

Volume:199.00

Turnover:4.67K

Market Cap:50.19M

PE:- -

High:23.63

Open:23.63

Low:23.63

Close:23.63

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals

Benzinga

·

19 Mar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FMED"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":23.63,"timestamp":1746022346589,"preClose":23.63,"halted":0,"volume":199,"delay":0,"floatShares":2123806,"shares":2123806,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"04-30 10:59:26 EDT","open":23.63,"high":23.63,"low":23.63,"amount":4674.356173,"amplitude":0,"askPrice":23.62,"askSize":555,"bidPrice":23.56,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":23.63,"sharesOutstanding":2123806,"nav":23.694969,"aum":50323517.332014,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.74,"preClose":23.63,"latestTime":"16:05 EDT","volume":2,"amount":47.26,"timestamp":1745957111654},"volumeRatio":0.24462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":2123806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.24462,"shares":2123806,"dividePrice":0.113,"high":23.63,"amplitude":0,"preClose":23.63,"low":23.63,"week52Low":20.69,"pbRate":"--","week52High":26.79,"institutionHeld":0,"latestPrice":23.63,"committee":-0.052133,"eps":0,"divideRate":0.004782,"volume":199,"delay":0,"ttmEps":0,"open":23.63,"prevYearClose":24.6605,"prevWeekClose":23.591,"prevMonthClose":23.61,"prevQuarterClose":23.61,"fiveDayClose":23.0224,"twentyDayClose":23.1526,"sixtyDayClose":26.07},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FMED\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520327379","title":"Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2520327379","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520327379?lang=en_us&edition=fundamental","pubTime":"2025-03-19 02:32","pubTimestamp":1742322730,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc.  following fourth-quarter results posted last month.Last month, the company reported a fourth-quarter 2024 adjusted EPS of $, missing the consensus estimate of $. However, sales for the quarter totaled $1.52 billion, which is in line with expectations.The analyst’s revised estimates reflect an updated outlook on AGL’s recovery timeline based on management’s recent commentary.With 2025 expected to be a year of transition, the company aims to address specific challenges while navigating another year of high trends, positioning itself to achieve its targets for 2026/2027, adds the analyst.The analyst estimates revenue of $1.502 billion  and adjusted EBITDA of $16 million  in the first quarter of FY25.For FY25, Gill revised the revenue estimate to $5.926 billion  from $6.453 billion earlier while adjusted EBITDA loss estimate remains unchanged at $77 million .For FY26, the analyst updated the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agilon-health-adjusts-recovery-phase-183210123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4196","AGL","FMED"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{}}}